Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for children, researchers must ensure that doses are properly recalculated and new side effects do not...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in the plenary hall and virtually to watch the Opening Plenary Session of the AACR Annual...
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option for patients with this disease, which causes almost 14,000 deaths each year, the majority of...
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating KRAS: A 30-year Overnight Sensation.” The plenary session was chaired by Dafna Bar-Sagi, PhD, FAACR,...
Researchers are striving to understand why men are more likely than women to get and die from many types of cancer.
While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now